Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days
Payers & Policy·Centers for Medicare & Medicaid Services

CMS cuts 2027 non-qualifying APM conversion factor 2.31% as a one-year boost expires

Medicare's final 2027 physician pay rule lowers both conversion factors as a one-year 2.5% increase lapses, while adding a 32% visit add-on for ACO clinicians and delaying a remote monitoring staffing limit to 2029.

From a CMS fact sheet and press release published Nov. 4, 2026, and the final rule published in the Federal Register Nov. 9, 2026
Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, in his official portrait.
Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, in his official portrait. File photo.Centers for Medicare & Medicaid Services (public domain)

Medicare's base rate for physician services is going down next year, even as the program steers extra money toward office visits, especially for clinicians in accountable care organizations.

The Centers for Medicare & Medicaid Services issued its final 2027 Physician Fee Schedule on Nov. 4. It sets the conversion factor for clinicians who are not qualifying APM participants at $32.63, a 2.31% decrease from the current $33.40, according to the agency's fact sheet. Clinicians who qualify through advanced alternative payment models get a separate factor of $32.95, down 1.83% from $33.57. The rule takes effect Jan. 1, 2027.

Why it matters: The conversion factor is the multiplier that turns each service's relative value units into a dollar payment, so a lower factor trims rates across the fee schedule before any service-specific change. The rule pairs that cut with targeted increases for evaluation and management visits, with the largest going to clinicians in ACOs.

The statutory updates for 2027 are 0.75% for qualifying APM participants and 0.25% for everyone else, CMS said, and both factors carry an estimated 0.12% downward adjustment tied to changes in work relative value units. Those updates are outweighed by the expiration of a one-year 2.5% increase for 2026 enacted in Public Law 119-21, which CMS calls the Working Families Tax Cut legislation. In effect, the agency said, current law requires a 2.5% reduction from 2026.

Where the money moves

CMS finalized turning the visit complexity add-on code G2211 into a modifier, B1, that raises payment for the associated office visit by 16% instead of paying a flat amount. A second modifier, B2, raises payment for an evaluation and management visit by 32% for practitioners in a Medicare Shared Savings Program ACO or a Long-term Enhanced ACO Design Model ACO. B2 is voluntary and can be billed for any beneficiary those practitioners see, not only patients assigned to the ACO, the agency said.

From April 1, 2027, ACOs that CMS approves can lower or waive Part B cost-sharing on many services for their assigned beneficiaries, according to CMS's press release.

The agency also scaled back a proposed cut for office visits billed on the same day as a procedure. The final policy applies only to procedures with 0-day global periods, not 10- or 90-day globals, and pays the lower-cost service at 80% rather than the proposed 50%.

"For too long, fee-for-service payment has rewarded volume over value, fueling a reactive system of sick care," CMS Administrator Dr. Mehmet Oz said in the release.

For remote physiologic and remote therapeutic monitoring, CMS finalized three proposals: limiting remote therapeutic monitoring to established patients, requiring clinicians to furnish a separately reportable initiating visit when monitoring begins, and revising how the services are valued. It pushed back to Jan. 1, 2029, a fourth proposal to pay for the services only when the practice's own employed clinical staff furnish them, which would end Medicare payment when contractors deliver them. CMS said the two-year delay gives practices more time to adapt.

What comes next

The rule caps annual Clinical Laboratory Fee Schedule payment reductions at 15% a year through 2029, under changes made by the Consolidated Appropriations Act, 2026. CMS will retire the traditional Merit-based Incentive Payment System reporting option starting with the 2031 performance period, two years later than it proposed, leaving clinicians through 2030 to move to MIPS Value Pathways or advanced APMs.

The rule also requires 340B covered entities to send claim-level data on certain Part D drugs to a CMS repository for dates of service from Jan. 1, 2027, with the first quarterly deadline set for Sept. 30, 2027. CMS issued its 2027 hospital outpatient rule, which cuts Medicare payment for 340B-acquired drugs, the same day.

The final rule was published in the Federal Register on Nov. 9. Next on the calendar are the Jan. 1 effective date and April 1, when ACOs can begin waiving cost-sharing.

Sara Montes de Oca is the Editor in Chief of Charted. She previously worked as a correspondent and producer in Washington, D.C., covering business, finance, and politics. Drafted with automated tools from the sources listed with this story and checked against them before publishing. How we report.

More Payers & Policy

More
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.